Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 461-465

  Suarez, Felipe ^a   Olivier, Gaelle ^b   Garcia Hermoso, Dea ^c,d   Randriamalala, Edouard ^b   Ghez, David ^a   Bruneau, Julie ^a   Kauffmann Lacroix, Catherine ^b   Bougnoux, Marie Elisabeth ^a   Lortholary, Olivier ^a,c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CASPOFUNGIN; CLOFARABINE; CORTICOSTEROID; CYTARABINE; ETOPOSIDE; GALACTOMANNAN; IDARUBICIN; IMMUNOGLOBULIN; MELPHALAN; MERCAPTOPURINE; VORICONAZOLE;

ACUTE BIPHENOTYPIC LEUKEMIA; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BASIDIOMYCETES; BRONCHUS OBSTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANDIDA ALBICANS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; FEMALE; HORMOGRAPHIELLA ASPERGILLATA; HORMOGRAPHIELLA ASPERGILLATA INFECTION; HUMAN; HYPOKALEMIA; LUNG ASPERGILLOSIS; LUNG MYCOSIS; MALE; MYCOSIS BY BASIDIOMYCETES; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINAL CORD DISEASE; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BASIDIOMYCOTA; DNA, FUNGAL; ECHINOCANDINS; FEMALE; FEVER OF UNKNOWN ORIGIN; FUNGI; HUMANS; LUNG DISEASES, FUNGAL; MALE; MOLECULAR SEQUENCE DATA; MYCOSES; NEUTROPENIA; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

BASIDIOMYCOTA; FUNGI;

EID: 78650860362     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01213-10     Document Type: Article

References (30)

1. Abuali, M. M., R. Posada, G. Del Toro, E. Roman, R. Ramani, S. Chaturvedi, V. Chaturvedi, and V. J. LaBombardi. 2009. Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J. Clin. Microbiol. 47:4176-4179.
2. Bartz-Schmidt, K. U., K. Tintelnot, M. Steffen, M. Ozel, B. Kirchhof, and K. Heimann. 1996. Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Graefes Arch. Clin. Exp. Ophthalmol. 234:591-593.
3. Betts, R. F., M. Nucci, D. Talwar, M. Gareca, F. Queiroz-Telles, R. J. Bedimo, R. Herbrecht, G. Ruiz-Palacios, J. H. Young, J. W. Baddley, K. M. Strohmaier, K. A. Tucker, A. F. Taylor, and N. A. Kartsonis. 2009. A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. Clin. Infect. Dis. 48:1676-1684.
4. Bitar, D., D. Van Cauteren, F. Lanternier, E. Dannaoui, D. Che, F. Dromer, J. C. Desenclos, and O. Lortholary. 2009. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg. Infect. Dis. 15:1395-1401.
5. Chittick, P., E. L. Palavecino, B. Delashmitt, J. Evans, and J. E. Peacock. 2009. Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrob. Agents Chemother. 53:5306-5307.
6. Conen, A., M. Weisser, D. Hohler, R. Frei, and M. Stern. 18 May 2010. Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clin. Microbiol. Infect. [Epub ahead of print.] doi:10.1111/j.1469-0691.2010. 03266.x.
7. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, A. Monzon, M. J. Buitrago, and J. L. Rodriguez-Tudela. 2009. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob. Agents Chemother. 53:2192-2195.
8. Dannaoui, E., M. Desnos-Ollivier, D. Garcia-Hermoso, D. Raoux, D. Hoinard, F. Dromer, and O. Lortholary. 2010. Infections due to Candida spp. with reduced susceptibility to caspofungin in France, abstr. 0346. 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria.
9. Fera, M. T., E. La Camera, and A. De Sarro. 2009. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev. Anti Infect. Ther. 7:981-998.
10. Gené, J., J. M. Guillamón, J. Guarro, I. Pujol, and K. Ulfig. 1996. Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek 70:49-57.
11. Greene, R. E., H. T. Schlamm, J. Oestmann, P. Stark, C. Durand, O. Lortholary, J. R. Wingard, R. Herbrecht, P. Ribaud, T. F. Patterson, P. F. Troke, D. W. Denning, J. E. Bennett, B. E. de Pauw, and R. H. Rubin. 2007. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin. Infect. Dis. 44:373-379.
12. Hahn-Ast, C., A. Glasmacher, S. Mückter, A. Schmitz, A. Kraemer, G. Marklein, P. Brossart, and M. von Lilienfeld-Toal. 2010. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J. Antimicrob. Chemother. 65:761-768.
13. Imhof, A., S. A. Balajee, D. N. Fredricks, J. A. Englund, and K. A. Marr. 2004. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin. Infect. Dis. 39:743-746.
14. Klingspor, L., and J. Loeffler. 2009. Aspergillus PCR formidable challenges and progress. Med. Mycol. 47(Suppl. 1):S241-S247.
15. Lacaz, C. D. S., E. M. Heins-Vaccari, N. T. De Melo, and G. L. Hernandez-Arriagada. 1996. Basidiomycosis: a review of the literature. Rev. Inst. Med. Trop. Sao Paulo 38:379-390.
16. Lagrou, K., C. Massonet, K. Theunissen, W. Meersseman, M. Lontie, E. Verbeken, J. Van Eldere, and J. Maertens. 2005. Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J. Med. Microbiol. 54:685-688.
17. Lanternier, F., and O. Lortholary. 2008. Liposomal amphotericin B: what is its role in 2008? Clin. Microbiol. Infect. 14(Suppl. 4):71-83.
18. Leeflang, M. M., Y. J. Debets-Ossenkopp, C. E. Visser, R. J. P. M. Scholten, L. Hooft, H. A. Bijlmer, J. B. Reitsma, P. M. Bossuyt, and C. M. Vandenbroucke-Grauls. 2008. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst. Rev. 2010:CD007394.
19. Maertens, J., I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, F. B. Petersen, C. A. Sable, N. A. Kartsonis, A. Ngai, A. Taylor, T. F. Patterson, D. W. Denning, and T. J. Walsh. 2004. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 39:1563-1571.
20. Mengoli, C., M. Cruciani, R. A. Barnes, J. Loeffler, and J. P. Donnelly. 2009. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9:89-96.
21. Nenoff, P., T. Friedrich, H. Schwenke, M. Mierzwa, L. C. Horn, and U. F. Haustein. 1997. Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. J. Med. Vet. Mycol. 35:65-69.
22. Neofytos, D., D. Horn, E. Anaissie, W. Steinbach, A. Olyaei, J. Fishman, M. Pfaller, C. Chang, K. Webster, and K. Marr. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265-273.
23. Pekic, S., V. A. Arsenijevic, M. S. Gazibara, T. Milojevic, I. Pendjer, M. Stojanovic, and V. Popovic. 2010. What lurks in the sellar? Lancet 375:432.
24. Rieger, C. T., and H. Ostermann. 2008. Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients. Mycoses 51(Suppl. 1):31-34.
25. Sable, C. A., K. M. Strohmaier, and J. A. Chodakewitz. 2008. Advances in antifungal therapy. Annu. Rev. Med. 59:361-379.
26. Speller, D. E., and A. G. MacIver. 1971. Endocarditis caused by a Coprinus species: a fungus of the toadstool group. J. Med. Microbiol. 4:370-374.
27. Suarez, F., O. Lortholary, S. Buland, M. T. Rubio, D. Ghez, V. Mahé, G. Quesne, S. Poirée, A. Buzyn, B. Varet, P. Berche, and M. E. Bougnoux. 2008. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. J. Clin. Microbiol. 46:3772-3777.
28. Surmont, I., F. Van Aelst, J. Verbanck, and G. S. De Hoog. 2002. A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. Med. Mycol. 40:217-219.
29. Verweij, P. E., M. van Kasteren, J. van de Nes, G. S. de Hoog, B. E. de Pauw, and J. F. Meis. 1997. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J. Clin. Microbiol. 35:2675-2678.
30. Walsh, T. J., E. J. Anaissie, D. W. Denning, R. Herbrecht, D. P. Kontoyiannis, K. A. Marr, V. A. Morrison, B. H. Segal, W. J. Steinbach, D. A. Stevens, J. van Burik, J. R. Wingard, and T. F. Patterson. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360.